Olga Laur1, Meredith A Brisco2, Alexander J Kula1, Susan J Cheng1, Abeel A Mangi1, Lavanya Bellumkonda1, Daniel L Jacoby1, Steven Coca1, W H Wilson Tang3, Chirag R Parikh1, Jeffrey M Testani4. 1. Department of Internal Medicine and the Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut, United States. 2. Department of Medicine, Cardiology Division, Medical University of South Carolina, Charleston, South Carolina, United States. 3. Department of Medicine, Cardiovascular Division, Cleveland Clinic Foundation, Cleveland, Ohio, United States. 4. Department of Internal Medicine and the Program of Applied Translational Research, Yale University School of Medicine, New Haven, Connecticut, United States. Electronic address: jeffrey.testani@yale.edu.
Abstract
BACKGROUND: Renal dysfunction (RD) is a potent risk factor for death in patients with cardiovascular disease. This relationship may be causal; experimentally induced RD produces findings such as myocardial necrosis and apoptosis in animals. Cardiac transplantation provides an opportunity to investigate this hypothesis in humans. METHODS AND RESULTS: Cardiac transplantations from the United Network for Organ Sharing registry were studied (n = 23,056). RD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2). RD was present in 17.9% of donors and 39.4% of recipients. Unlike multiple donor characteristics, such as older age, hypertension, or diabetes, donor RD was not associated with recipient death or retransplantation (age-adjusted hazard ratio [HR] = 1.00, 95% confidence interval [CI] 0.94-1.07, P = .92). Moreover, in recipients with RD the highest risk for death or retransplantation occurred immediately posttransplant (0-30 day HR = 1.8, 95% CI 1.54-2.02, P < .001) with subsequent attenuation of the risk over time (30-365 day HR = 0.92, 95% CI 0.77-1.09, P = .33). CONCLUSIONS: The risk for adverse recipient outcomes associated with RD does not appear to be transferrable from donor to recipient via the cardiac allograft, and the risk associated with recipient RD is greatest immediately following transplant. These observations suggest that the risk for adverse outcomes associated with RD is likely primarily driven by nonmyocardial factors.
BACKGROUND:Renal dysfunction (RD) is a potent risk factor for death in patients with cardiovascular disease. This relationship may be causal; experimentally induced RD produces findings such as myocardial necrosis and apoptosis in animals. Cardiac transplantation provides an opportunity to investigate this hypothesis in humans. METHODS AND RESULTS: Cardiac transplantations from the United Network for Organ Sharing registry were studied (n = 23,056). RD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2). RD was present in 17.9% of donors and 39.4% of recipients. Unlike multiple donor characteristics, such as older age, hypertension, or diabetes, donor RD was not associated with recipient death or retransplantation (age-adjusted hazard ratio [HR] = 1.00, 95% confidence interval [CI] 0.94-1.07, P = .92). Moreover, in recipients with RD the highest risk for death or retransplantation occurred immediately posttransplant (0-30 day HR = 1.8, 95% CI 1.54-2.02, P < .001) with subsequent attenuation of the risk over time (30-365 day HR = 0.92, 95% CI 0.77-1.09, P = .33). CONCLUSIONS: The risk for adverse recipient outcomes associated with RD does not appear to be transferrable from donor to recipient via the cardiac allograft, and the risk associated with recipient RD is greatest immediately following transplant. These observations suggest that the risk for adverse outcomes associated with RD is likely primarily driven by nonmyocardial factors.
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: Eric S Weiss; Jeremiah G Allen; Arman Kilic; Stuart D Russell; William A Baumgartner; John V Conte; Ashish S Shah Journal: J Heart Lung Transplant Date: 2011-11-16 Impact factor: 10.247
Authors: Jeffrey M Testani; Meredith A Brisco; Gang Han; Olga Laur; Alexander J Kula; Susan J Cheng; Wai Hong Wilson Tang; Chirag R Parikh Journal: Am J Cardiol Date: 2013-10-03 Impact factor: 2.778
Authors: Steven R Meyer; Dennis L Modry; Colleen M Norris; Glen J Pearson; Michael J Bentley; Arvind Koshal; John C Mullen; Ivan M Rebeyka; David B Ross; Shaohua Wang Journal: J Card Surg Date: 2006 Mar-Apr Impact factor: 1.620
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690